您当前的位置：
首页 >
文章列表页 >
Interpretation of Evidence-to-decision Framework and Its Application in Pharmacovigilance Guidelines of Chinese Patent Medicines
更新时间：2026-03-19

    • Interpretation of Evidence-to-decision Framework and Its Application in Pharmacovigilance Guidelines of Chinese Patent Medicines

    • Chinese Journal of Experimental Traditional Medical Formulae   Vol. 32, Issue 8, Pages: 220-228(2026)

    • DOI：10.13422/j.cnki.syfjx.20260894    

      CLC： R242;R856.2;R2-03

    • Received：01 December 2025，

      Online First：13 February 2026，

      Published：20 April 2026

    移动端阅览

  • ZHANG Hongyan,CUI Xin,LI Yuanyuan,et al.Interpretation of Evidence-to-decision Framework and Its Application in Pharmacovigilance Guidelines of Chinese Patent Medicines[J].Chinese Journal of Experimental Traditional Medical Formulae,2026,32(08):220-228. DOI： 10.13422/j.cnki.syfjx.20260894.

  •  
  •  

0

Views

9

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Compilation Instruction and Key Point Interpretation for Pharmacovigilance Guidelines for Clinical Application of Chinese Patent Medicines for Mucosal Administration
Compilation Instruction for Pharmacovigilance Guidelines for Clinical Application of Traditional Chinese Medicine Injections
Compilation Instruction for Pharmacovigilance Guideline for Clinical Application of Chinese Patent Medicine for External Use

Related Author

LI Wenzhe
MA Rui
ZHAO Xiaoxiao
HUA Hong
CUI Xin
XIE Yanming
WANG Lianxin
FU Changkuan

Related Institution

Peking University School and Hospital of Stomatology
Institute of Basic Research in Clinical Medicine，China Academy of Chinese Medical Sciences
General Hospital of Ningxia Medical University
Yunnan Provincial Hospital of Traditional Chinese Medicine
The Third Affiliated Hospital of Changchun University of Chinese Medicine
0